ACTIVITY OVERVIEW
This content of the FREE virtual lecture was derived from a live, educational teleconference/webcast presented by the Crohn’s & Colitis Foundation of America on Thursday, May 7, 2009.

The virtual lecture format enables you to:

• View presentation slides and listen to the audio simultaneously
• Download a transcript of the presentation
• Download a copy of the presentation slides

Registered nurses can participate in the learning assessment and complete an Evaluation form to receive continuing nursing education credit.

Patients and caregivers can participate by completing an Evaluation form to help us plan for future educational activities.

MEDIUM: Virtual Lecture
INTERNET RELEASE DATE: May 8, 2009
(Continuing education credit is no longer available for this activity.)

Estimated time to complete this activity: 1.5 hours

SPEAKER
Stephen B. Hanauer, MD
Professor of Medicine and Clinical Pharmacology
University of Chicago Pritzker School of Medicine
Chief of Gastroenterology, Hepatology, and Nutrition
University of Chicago Medical Center
Chicago, Illinois

TARGET AUDIENCE
This activity has been designed to meet the educational needs of registered nurses who are involved in the diagnosis, treatment, and education of patients with inflammatory bowel diseases (IBD).

ACTIVITY PURPOSE
This activity is intended to assist nursing professionals in understanding how to manage patients with inflammatory bowel diseases.

STATEMENT OF NEED
An estimated 1.4 million people in the United States are living with inflammatory bowel diseases (IBD), a serious and complex group of chronic intestinal diseases characterized by inflammation of the bowel.1 Ulcerative colitis and Crohn’s disease are the most common forms of IBD.2 A continuum of drug therapy and surgical treatment options exist for IBD, each with distinct risks, benefits, and side effects.3,4 In addition, a growing number of emerging therapies for IBD are currently under investigation.5,6 Managing IBD can be complicated, and usually requires a lifetime of medical care.1 Disease course is impacted by many factors including genetics, treatment choice, adherence to prescribed treatment and lifestyle issues. More than 40% of patients do not adhere to their medication and thus a significant number of patients are not receiving the full benefits from their treatment.7 It is crucial that healthcare professionals have current education on IBD in order to effectively help patients understand their range of treatment options, the importance of adherence to prescribed treatment plans, and the many lifestyle factors that impact the diseases.

¹ Crohn’s & Colitis Foundation of America. Living with Crohn’s disease. Available at: www.ccfa.org/frameviewer/?url=/media/pdf/crohns2005.pdf.
   Accessed May 4, 2009.
² Centers for Disease Control and Prevention. Inflammatory Bowel Disease (IBD). Available at: www.cdc.gov/nccdphp/dach/ibd.htm. Accessed
   March 20, 2009.
³ Oldenberg B, Hommes D. Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr Opin Gastroenterol. 2007;23:
   395-399.
⁴ Crohn’s & Colitis Foundation of America. Treatment options in IBD. Available at: www.ccfa.org/info/treatment. Accessed March 18, 2009.
⁵ Nakamura T, et al. Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis. Digestion. 2008;77:36-41.
⁶ Peyrin-Biroulet L, et al. Crohn’s disease: beyond antagonists of tumour necrosis factor. Lancet. 2008;372:67-81.
⁷ Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther.
   2008;27:9-14.

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be better able to:

• Outline the current and emerging therapies for inflammatory bowel disease (IBD)
• Identify the differences between “top-down” and “bottom-up” approaches to treatment
• Identify lifestyle factors, including diet, smoking, and stress that affect IBD disease course
• Cite the physical and monetary costs of IBD
• Describe current research involving genetics, causation, and novel treatments for IBD
• Review quality-of-life issues in living with IBD

METHOD OF PARTICIPATION
There are no fees for participating and receiving continuing education (CE) credit for this activity. During the period May 8, 2009, through May 8, 2010, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the Learning Assessment by recording the best answer to each question in the “Learning Assessment Answers” box on the Evaluation form; 4) complete the Evaluation form; and 5) mail or fax the Evaluation form with the Learning Assessment answers to Postgraduate Institute for Medicine. You may also complete the Learning Assessment online at www.cmeuniversity.com. Click on “Find Post-Test/Evaluation by Course” on the navigation menu, and search by Project ID 6495.

Participants must receive a score of at least 70% on the Learning Assessment and must complete and submit the Evaluation form to successfully complete this activity. Participants who successfully complete the Learning Assessment and Evaluation form via www.cmeuniversity.com will have a statement of credit made available immediately.

Participants who successfully complete this activity and submit the Learning Assessment and Evaluation form via fax or mail will be issued a statement of credit via US mail in 4 to 6 weeks.

NURSING CONTINUING EDUCATION
CREDIT DESIGNATION
This educational activity for 1.5 contact hours is provided by Postgraduate Institute for Medicine (PIM).

ACCREDITATION STATEMENT
Postgraduate Institute for Medicine is accredited as a provider of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.




CALIFORNIA BOARD OF REGISTERED NURSING
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.8 contact hours.

A statement of credit will be issued only upon receipt of a completed activity Evaluation form and will be mailed to you in 4 to 6 weeks.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity:

• Dr. Stephen B. Hanauer has affiliations with Abbott Laboratories; Centocor, Inc.; Elan Pharmaceuticals, Inc.; Ferring Pharmaceuticals; Procter & Gamble Pharmaceuticals; Prometheus; Salix Pharmaceuticals, Inc.; Shire; and UCB Pharma (Consultant, Clinical Research); and AstraZeneca; McNeil-PPC, Inc.; and Millennium Pharmaceuticals, Inc. (Consultant).

The following planners and managers have the following to disclose:

Crohn’s & Colitis Foundation of America

• Amanda Douglas has no affiliations with commercial interests to disclose.
• Kimberly Frederick has no affiliations with commercial interests to disclose.
• Jacquelyn Spencer has no affiliations with commercial interests to disclose.

Robert Michael Educational Institute LLC

• Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
• Lora Rhodes, LSW, Educational Content Manager, has no affiliations with commercial interests to disclose.
• Elise Paxson, Content Manager, has no affiliations with commercial interests to disclose.
• Laura Altobelli, MS, Content Manager, has no affiliations with commercial interests to disclose.

Postgraduate Institute for Medicine

• Jan Hixon, RN, BSN, MA, has no affiliations with commercial interests to disclose.
• Linda Graham, RN, BSN, has no affiliations with commercial interests to disclose.
• Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose.
• Julia Kirkwood, RN, BSN, has no affiliations with commercial interests to disclose.
• Jan Schultz, RN, MSN, CCMEP, has no affiliations with commercial interests to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), RMEI, CCFA and Procter & Gamble Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, RMEI, CCFA and Procter & Gamble Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

SUPPORT STATEMENT
This continuing education activity is co-provided by Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine, in collaboration with the Crohn’s & Colitis Foundation of America.

This activity is supported by an independent educational grant from Procter & Gamble Pharmaceuticals.

FEE INFORMATION
There is no fee for this educational activity.

QUESTIONS & TECHNICAL ASSISTANCE
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity: jjones@pimed.com. For technical assistance, contact jungsen@rmcom.net.

SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - AOL 8
  - Mozilla Firefox 1.0+
• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+
• Additional Requirements
  - Windows Media Player or RealPlayer
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

For more information about the Crohn’s & Colitis Foundation of America, visit www.ccfa.org.

Additional educational activities offered by Robert Michael Educational Institute LLC can be found at www.RMEI.com or by calling toll-free to 866-770-RMEI.

PIM Privacy Policy        RMEI Privacy Statement